ライフサイエンスコーパス: oral antibiotic

1 70 paired cases (differing only in receiving oral antibiotics).

2 tool culture, and the patient improved on an oral antibiotic.

3 oms, completion of 10 days of treatment with oral antibiotics.

4 revalence of resistance to readily available oral antibiotics.

5 It was successfully treated with oral antibiotics.

6 main asymptomatic when they are treated with oral antibiotics.

7 operative normothermia, glucose control, and oral antibiotics.

8 s, each of whom received repeated courses of oral antibiotics.

9 whereas 36.4% received a mechanical prep and oral antibiotics.

10 ing only in whether or not they had received oral antibiotics.

11 n a cohort of commonly prescribed off-patent oral antibiotics.

12 en whose bacterial vaginosis is treated with oral antibiotics.

13 se exacerbations are frequently treated with oral antibiotics.

14 patients received long-term suppression with oral antibiotics (31 of 74 [42%] ceftriaxone vs 25 of 50

15 testinal microbiota was depleted by means of oral antibiotic administration.

16 ed on limited evidence from trials comparing oral antibiotic agents with topical antibiotics.

17 ure through processed food, formula milk and oral antibiotic and drug use.

18 tic-glucocorticoid eardrops were superior to oral antibiotics and initial observation for all outcome

19 ocorticoid eardrops were more effective than oral antibiotics and initial observation in children wit

20 Treatment with long-term, non-Pseudomonas oral antibiotics and integration of CF infants with olde

21 available agents for acne treatment, such as oral antibiotics and isotretinoin (Accutane), have limit

22 Use of broad-spectrum oral antibiotics and probably poor infection control pra

23 However, oral antibiotics are available that achieve adequate lev

24 Topical and oral antibiotics are routinely used to treat acne.

25 Although oral antibiotics are used commonly in the management of

26 children) with osteomyelitis, 1005 received oral antibiotics at discharge, whereas 1055 received PIC

27 The limited oral antibiotics available and the growing resistance to

28 espiratory tract infection and prescribed an oral antibiotic between January 2015 and April 2016 in a

29 r the extremely aggressive and timely use of oral antibiotics by all asymptomatics in the exposure re

30 A) and initiation of topical treatments and oral antibiotics by primary care clinicians (algorithm B

31 Treating mdr1a-/- mice with oral antibiotics can both prevent the development of dis

32 ation in CF was tested by treating mice with oral antibiotics (ciprofloxacin and metronidazole) for 3

33 h more severe inflammatory acne usually need oral antibiotics combined with topical benzoyl peroxide

34 sized that mechanical bowel preparation with oral antibiotics (compared with without) was associated

35 17 of 41 patients had 24 fewer oral antibiotic courses when on azithromycin than when t

36 ut commensal bacteria in IL-6(+/+) mice with oral antibiotics decreased portal blood endotoxin levels

37 s, making therapy of urinary infections with oral antibiotics difficult.

38 ged from hospital on post-operative day 3 on oral antibiotics for 7 days.

39 e two trials, treatment with intravenous and oral antibiotics for 90 days did not improve symptoms mo

40 h existing studies comparing intravenous and oral antibiotics for this purpose are limited.

41 two or more weeks of ceftazidime followed by oral antibiotics for three to six months.

42 hould be considered eligible for combination oral antibiotics from the outset.

43 al bowel preparation given nor nonabsorbable oral antibiotic given).

44 Here we report that oral antibiotics given during active disease removed har

45 ia, postoperative day 1 glucose control, and oral antibiotics given when bowel prep used (SCIP-1 was

46 bers of injectable antibiotics combined with oral antibiotics had similar efficacy and safety to the

47 w studies that have assessed the efficacy of oral antibiotics in clinically meaningful ways in the ma

48 ification and recognition of the efficacy of oral antibiotics in low-risk patients.

49 ibe a unique disease-associated tolerance to oral antibiotics in superspreaders that facilitates cont

50 studied the relationship between the use of oral antibiotics in the first year of life and asthma, a

51 hanical bowel preparation with nonabsorbable oral antibiotics is associated with a decreased rate of

52 existing studies on the topic indicate that oral antibiotics may be an effective treatment for OSD t

53 Oral antibiotics may be rapidly substituted for intraven

54 Oral antibiotics may reduce the incidence of SSI.

55 e absence of IRF4 or after administration of oral antibiotics, MHC II(+)CD226(-)CD11c(-) monocyte-der

56 ion, postprocedural fever that resolved with oral antibiotics, occurred (1%; 95% CI: 0%, 6%).

57 containing vancomycin, teicoplanin, and six oral antibiotics of potential use in periodontal therapy

58 onversely, disruption of the microbiota with oral antibiotics often precedes the emergence of several

59 In NHE3(-/-) mice, broad-spectrum oral antibiotics or anti-asialo GM1 antibodies reduce th

60 Modulation of intestinal microbiota by oral antibiotics or germ-free condition can prevent arth

61 hanical bowel preparation with nonabsorbable oral antibiotics) or no bowel preparation (neither mecha

62 ardrops versus 5 days for those treated with oral antibiotics (P<0.001) and 12 days for those who wer

63 ation they received [combined mechanical and oral antibiotic preparation (OAP), mechanical preparatio

64 , defined as the excess percentage change in oral antibiotic prescription rates in Knox County betwee

65 nfidence intervals of ambulatory visits with oral antibiotic prescriptions by age, region, and diagno

66 Oral antibiotic prescriptions dispensed during 2011 were

67 monella-infected hosts that are treated with oral antibiotics rapidly shed superspreader levels of th

68 We extracted oral antibiotics recommended for common outpatient condi

69 MBP with oral antibiotics reduces by nearly half, SSI, anastomoti

70 ined before transitioning to a dual-targeted oral antibiotic regimen.

71 Two of three oral antibiotic regimens--1) amoxicillin, 750 mg three t

72 el preparation with mechanical cleansing and oral antibiotics results in a significantly lower incide

73 , as compared with 44% of those treated with oral antibiotics (risk difference, -39 percentage points

74 were corrected by a course of broad-spectrum oral antibiotics started at weaning, indicating that the

75 Oral antibiotics still have a role in the treatment of m

76 Oral antibiotics such as metronidazole, vancomycin and f

77 adjusted for renal function), with possible oral antibiotic switch after >/=5 days (total treatment

78 g in neonatal bag and mask resuscitation and oral antibiotic therapy for suspected neonatal infection

79 usually resolved during a 1-month course of oral antibiotic therapy, the median antibody titers to m

80 to guide the transition from intravenous to oral antibiotic therapy.

81 to shift management of severe pneumonia with oral antibiotics to outpatients in the community.

82 n with Listeria monocytogenes, germ-free and oral-antibiotic-treated mice display increased pathogen

83 Oral antibiotic treatment eliminated spontaneous autoimm

84 utyrate-producing Clostridia, either through oral antibiotic treatment or as part of the pathogen-ind

85 ation of commensal bacterial populations via oral antibiotic treatment resulted in elevated serum IgE

86 roxide should always be added when long-term oral antibiotic use is deemed necessary.

87 cal modalities, and limiting the duration of oral antibiotic use.

88 ciated with decreased rates of postoperative oral antibiotic use.

89 Compared with oral antibiotics, use of intravenous antibiotics after d

90 The incidence of intolerance of the oral antibiotics was 16 percent, as compared with 8 perc

91 Mechanical bowel prep without oral antibiotics was administered to 49.6% of patients,

92 Patients receiving bowel prep with oral antibiotics were also less likely to have a prolong

93 ted with routinely prescribing postoperative oral antibiotics were India (odds ratio [OR], 15.83; 95%

94 Patients receiving oral antibiotics were less likely to have any SSI (4.5%

95 s and the number of manufacturers for common oral antibiotics were overall stable between 2013 and 20

96 Outpatient management and oral antibiotics were safe in low-risk FN with no infect

97 and fewer than 29% to 46% were converted to oral antibiotics within 1 day of stability, depending on